Amphastar Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent
Amphastar Pharmaceuticals, Inc. (AMPH) reported Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent of 89.60% for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-15.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities · last filed 2019-03-15
- Amphastar Pharmaceuticals, Inc. effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2017 was 89.60%, a 929.89% increase from fiscal 2016.
- Amphastar Pharmaceuticals, Inc. effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2016 was 8.70%.
- Amphastar Pharmaceuticals, Inc. effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2013 was -3.30%.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent 12 month | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent 12 month as first filed |
|---|---|---|
| 2017-12-31 | 89.60% 10-K · filed 2019-03-15 | 69.00% 10-K · filed 2018-03-14 |
| 2016-12-31 | 8.70% 10-K · filed 2018-03-14 | |
| 2013-12-31 | -3.30% 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |